Search

everythinglearnresearchcommunity

for

Search:↓

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Pexidartinib often causes liver issues and fatigue, especially in women.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Excessive selenium from a supplement caused toxicity but patients recovered with care.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Bicalutamide may help treat female pattern hair loss.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Breast implants are generally safe, but textured implants may rarely cause lymphoma.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Finasteride can cause sexual problems and depression in young men.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Pegvaliase is recommended for treating adults with phenylketonuria.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.